CATHERINE KITCHENS: Open Payments
NPI 1588991913 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 31 payments from 16 companies in 2025. Trend: 2023 $2,140 · 2024 $1,950 · 2025 $1,113
Food & beverage: $1,113
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $213 |
| Regeneron Healthcare Solutions, Inc. | 3 | $191 |
| PFIZER INC. | 4 | $175 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $117 |
| ABBVIE INC. | 3 | $70 |
| Galderma Laboratories, L.P. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| GENZYME CORPORATION | 1 | $48 |
| Janssen Biotech, Inc. | 2 | $43 |
| LEO Pharma Inc. | 2 | $36 |
Products named: DUPIXENT, CIBINQO, COSENTYX, SKYRIZI, NEMLUVIO, Sotyktu, TREMFYA, ADBRY.
Industry payments across GA — which companies pay providers there.
